3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Drug-Related Side Effects and Adverse Reactions
3
Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematologic Neoplasms
2
Brain Neoplasms
2
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pneumonia
1
Oropharyngeal Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hepatectomy
1
Down Syndrome
1
Cranial Nerve Diseases
1
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Methylprednisolone
×
1 year
×
Clear all
No trials found.